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A multitude of complex polysaccha- 
rides are known to alter host resistance to 
hacterinl infvdioii. Tiwr inclurlc bac- 
terial endotoxins (lipopolysaccharides), 
bacterial capsules, yeast cell walls (zym- 
man) ,  and other chemically complex sub- 
stances of microbial or botanical origin. 
At times it is possible to demonstrate ei- 
ther an increased susceptibility to irif ec- 
tion or an elevated resistance following 
the administration of the same com- 
pound. This has been accomplished by 
manipulating the dosage, route of injec- 
tion, and regimen of inoculation of the 
material before bacterial challeng-e. These 
complexes induce changes in the physio- 
logic state of the host and not in the viru- 
lence o f  the infecting agent. Although the 
mechanisms for altered host resistance are 
not clcar, the functional capacity of the 
reticuloendotheli~l system has ofte:i been 
cited as an important factor ( Henacerraf 
and Sebestyen, 1957; Riozzi et al, 1955). 
~- ' That many other factors of both a cellular 
and humoral nature are operative is evi- 
dent from the extensive literature pub- 
lishetl within the recent past on the subject 
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of natural resistance to infections ( Shilo, 
1959 ; McDermott and Kiw-, 1956). 
A niajur difficulty in the interpretation 
of data on the relationship between bac- 
terial liljopolysaccharitle., and altered host 
resistance is the chemical complexity of 
endotoxins. Hestrin (1956) has empha- 
sized that a detailed and systematic study 
of simple polysaccharides and how they 
impinge upon natural resistance might 
provide a sound basis for explanation of 
the Liological properties exhibited by 
chemically undefined bacterial somatic 
antigens. Simple polysaccharides like 
dextrans and levans are compounds of 
uniform structure which yield 1 hexose 
residue on hydrolysis and which differ 
only in molecular weight and degree of 
branching. Purified levans have been re- 
ported to affect adversely intradermal 
and inti-aperitoneai infections with a 
number of bacterial agents. The infec- 
tion-promoting ability of these polysac- 
charides was attributed to a suppression 
of inflammation and an inhibition of an- 
tibacterial substances moving from the 
circulation to local areas of infection in 
the skin or peritoneal cavity (Shilo et al, 
1956; Shilo and Wolman, 1958). How- 
ever, the effect of neutral dextrans and 
their acidic derivatives on host resistance 
has not been studied as extensively. Since 
these compounds and their sulfated deriv- 
atives can be obtained in relatively pure 
form and in a variety of molecular 
weights, they lend thernsrlvcs readily to 
studies concerning natural resistance. 
This communication describes the 
effect of several dextrans and dextran 
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